Revue medicale suisse
Procopiou M.
PMID: 16025886
Rev Med Suisse. 2005 Jun 01;1(22):1480-4.
The benefits of screening for type 2 diabetes during its preclinical phase are not well established in comparison to starting a treatment after a diagnosis is made when the patient presents with symptoms of hyperglycaemia. Despite this uncertainty, it...
Cite
Procopiou M. Dépistage et diagnostic: du diabète de type 2: quels tests? [Diagnosis and screening for type 2 diabetes: which test to use?]. Rev Med Suisse. 2005;1(22):1480-4
Procopiou, M. (2005). Dépistage et diagnostic: du diabète de type 2: quels tests? [Diagnosis and screening for type 2 diabetes: which test to use?]. Revue medicale suisse, 1(22), 1480-4.
Procopiou, M. "Dépistage et diagnostic: du diabète de type 2: quels tests?" [Diagnosis and screening for type 2 diabetes: which test to use?]. Revue medicale suisse vol. 1,22 (2005): 1480-4.
Procopiou M. Dépistage et diagnostic: du diabète de type 2: quels tests? [Diagnosis and screening for type 2 diabetes: which test to use?]. Rev Med Suisse. 2005 Jun 01;1(22):1480-4. French. PMID: 16025886.
Copy
Download .nbib
Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Mora PF.
PMID: 20517164
J Investig Med. 2010 Aug;58(6):755-63. doi: 10.231/JIM.0b013e3181e61a64.
Transplantation medicine has grown to be an important element of medical practice, and with the development of modern immunosuppression agents and protocols, the occurrence of diabetes as renal transplantation is recognized as one of the metabolic consequences of therapy...
Cite
Mora PF. New-onset diabetes after renal transplantation. J Investig Med. 2010;58(6):755-63doi: 10.231/JIM.0b013e3181e61a64.
Mora, P. F. (2010). New-onset diabetes after renal transplantation. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 58(6), 755-63. https://doi.org/10.231/JIM.0b013e3181e61a64
Mora, Pablo F. "New-onset diabetes after renal transplantation." Journal of investigative medicine : the official publication of the American Federation for Clinical Research vol. 58,6 (2010): 755-63. doi: https://doi.org/10.231/JIM.0b013e3181e61a64
Mora PF. New-onset diabetes after renal transplantation. J Investig Med. 2010 Aug;58(6):755-63. doi: 10.231/JIM.0b013e3181e61a64. PMID: 20517164.
Copy
Download .nbib
Clinical journal of the American Society of Nephrology : CJASN
Bloom RD, Crutchlow MF.
PMID: 18309002
Clin J Am Soc Nephrol. 2008 Mar;3:S38-48. doi: 10.2215/CJN.02650707.
Advancing care has markedly improved survival after kidney transplantation, leaving patients susceptible to the effects of chronic transplant-associated morbidities. New-onset diabetes mellitus (NODM) is common in kidney recipients, threatening health and longevity by predisposing to microvascular and cardiovascular disease...
Cite
Bloom RD, Crutchlow MF. New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies. Clin J Am Soc Nephrol. 2008;3:S38-48doi: 10.2215/CJN.02650707.
Bloom, R. D., & Crutchlow, M. F. (2008). New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies. Clinical journal of the American Society of Nephrology : CJASN, 3S38-48. https://doi.org/10.2215/CJN.02650707
Bloom, Roy D, and Crutchlow, Michael F. "New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies." Clinical journal of the American Society of Nephrology : CJASN vol. 3 (2008): S38-48. doi: https://doi.org/10.2215/CJN.02650707
Bloom RD, Crutchlow MF. New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies. Clin J Am Soc Nephrol. 2008 Mar;3:S38-48. doi: 10.2215/CJN.02650707. PMID: 18309002; PMCID: PMC3152270.
Copy
Download .nbib
Ugeskrift for laeger
de Fine Olivarius N.
PMID: 23094285
Ugeskr Laeger. 2012 Aug 27;174(35):2032-3; discussion 2026.
No abstract available.
Cite
de Fine Olivarius N. Ingen evidens for befolkningsbaseret screening for type 2-diabetes. [No evidence for population-based screening for type 2-diabetes]. Ugeskr Laeger. 2012;174(35):2032-3; discussion 2026
de Fine Olivarius, N. (2012). Ingen evidens for befolkningsbaseret screening for type 2-diabetes. [No evidence for population-based screening for type 2-diabetes]. Ugeskrift for laeger, 174(35), 2032-3; discussion 2026.
de Fine Olivarius, Niels. "Ingen evidens for befolkningsbaseret screening for type 2-diabetes." [No evidence for population-based screening for type 2-diabetes]. Ugeskrift for laeger vol. 174,35 (2012): 2032-3; discussion 2026.
de Fine Olivarius N. Ingen evidens for befolkningsbaseret screening for type 2-diabetes. [No evidence for population-based screening for type 2-diabetes]. Ugeskr Laeger. 2012 Aug 27;174(35):2032-3; discussion 2026. Danish. PMID: 23094285.
Copy
Download .nbib
Mayo Clinic proceedings
Davidson JA.
PMID: 21106869
Mayo Clin Proc. 2010 Dec;85(12):S3-4. doi: 10.4065/mcp.2010.0466. Epub 2010 Nov 24.
No abstract available.
Cite
Davidson JA. The increasing role of primary care physicians in caring for patients with type 2 diabetes mellitus. Mayo Clin Proc. 2010;85(12):S3-4doi: 10.4065/mcp.2010.0466.
Davidson, J. A. (2010). The increasing role of primary care physicians in caring for patients with type 2 diabetes mellitus. Mayo Clinic proceedings, 85(12), S3-4. https://doi.org/10.4065/mcp.2010.0466
Davidson, Jaime A. "The increasing role of primary care physicians in caring for patients with type 2 diabetes mellitus." Mayo Clinic proceedings vol. 85,12 (2010): S3-4. doi: https://doi.org/10.4065/mcp.2010.0466
Davidson JA. The increasing role of primary care physicians in caring for patients with type 2 diabetes mellitus. Mayo Clin Proc. 2010 Dec;85(12):S3-4. doi: 10.4065/mcp.2010.0466. Epub 2010 Nov 24. PMID: 21106869; PMCID: PMC2996164.
Copy
Download .nbib
Diabetologia
Sawicki PT.
PMID: 22526615
Diabetologia. 2012 Jun;55(6):1568-71. doi: 10.1007/s00125-012-2553-x. Epub 2012 Apr 19.
This commentary discusses whether screening for type 2 diabetes or earlier normalisation of blood glucose levels or initiation of non-antihyperglycaemic agents or any other diabetes-specific treatment can help reduce the excess associated risks for macrovascular morbidity and mortality. The...
Cite
Sawicki PT. Screening for diabetes: hope and despair. Diabetologia. 2012;55(6):1568-71doi: 10.1007/s00125-012-2553-x.
Sawicki, P. T. (2012). Screening for diabetes: hope and despair. Diabetologia, 55(6), 1568-71. https://doi.org/10.1007/s00125-012-2553-x
Sawicki, P T. "Screening for diabetes: hope and despair." Diabetologia vol. 55,6 (2012): 1568-71. doi: https://doi.org/10.1007/s00125-012-2553-x
Sawicki PT. Screening for diabetes: hope and despair. Diabetologia. 2012 Jun;55(6):1568-71. doi: 10.1007/s00125-012-2553-x. Epub 2012 Apr 19. PMID: 22526615.
Copy
Download .nbib
Pathology
Backholer K, Chen L, Shaw J.
PMID: 22228253
Pathology. 2012 Feb;44(2):110-4. doi: 10.1097/PAT.0b013e32834e8e12.
The prevalence of type 2 diabetes is rapidly increasing. A strong rationale exists for identifying asymptomatic individuals who are at high risk or are likely to have diabetes. Screening programs may provide a conduit through which diabetes intervention may...
Cite
Backholer K, Chen L, Shaw J. Screening for diabetes. Pathology. 2012;44(2):110-4doi: 10.1097/PAT.0b013e32834e8e12.
Backholer, K., Chen, L., & Shaw, J. (2012). Screening for diabetes. Pathology, 44(2), 110-4. https://doi.org/10.1097/PAT.0b013e32834e8e12
Backholer, K, et al. "Screening for diabetes." Pathology vol. 44,2 (2012): 110-4. doi: https://doi.org/10.1097/PAT.0b013e32834e8e12
Backholer K, Chen L, Shaw J. Screening for diabetes. Pathology. 2012 Feb;44(2):110-4. doi: 10.1097/PAT.0b013e32834e8e12. PMID: 22228253.
Copy
Download .nbib
Advances in experimental medicine and biology
Imam K.
PMID: 23393689
Adv Exp Med Biol. 2012;771:340-55. doi: 10.1007/978-1-4614-5441-0_25.
Diabetes mellitus is a metabolic disorder of glucose homeostasis and associated with long-term vascular complications leading to morbidity and mortality. It is the fastest growing non-communicable disease throughout the world. The pathophysiology of diabetes is complex and multifactorial. Understanding...
Cite
Imam K. Clinical features, diagnostic criteria and pathogenesis of diabetes mellitus. Adv Exp Med Biol. 2012;771:340-55doi: 10.1007/978-1-4614-5441-0_25.
Imam, K. (2012). Clinical features, diagnostic criteria and pathogenesis of diabetes mellitus. Advances in experimental medicine and biology, 771340-55. https://doi.org/10.1007/978-1-4614-5441-0_25
Imam, Khalid. "Clinical features, diagnostic criteria and pathogenesis of diabetes mellitus." Advances in experimental medicine and biology vol. 771 (2012): 340-55. doi: https://doi.org/10.1007/978-1-4614-5441-0_25
Imam K. Clinical features, diagnostic criteria and pathogenesis of diabetes mellitus. Adv Exp Med Biol. 2012;771:340-55. doi: 10.1007/978-1-4614-5441-0_25. PMID: 23393689.
Copy
Download .nbib
Lancet (London, England)
Gale EA.
PMID: 23725732
Lancet. 2013 Jun 01;381(9881):1956-7. doi: 10.1016/S0140-6736(12)62207-7.
No abstract available.
Cite
Gale EA. Is type 2 diabetes a category error?. Lancet. 2013;381(9881):1956-7doi: 10.1016/S0140-6736(12)62207-7.
Gale, E. A. (2013). Is type 2 diabetes a category error?. Lancet (London, England), 381(9881), 1956-7. https://doi.org/10.1016/S0140-6736(12)62207-7
Gale, Edwin A M. "Is type 2 diabetes a category error?." Lancet (London, England) vol. 381,9881 (2013): 1956-7. doi: https://doi.org/10.1016/S0140-6736(12)62207-7
Gale EA. Is type 2 diabetes a category error?. Lancet. 2013 Jun 01;381(9881):1956-7. doi: 10.1016/S0140-6736(12)62207-7. PMID: 23725732.
Copy
Download .nbib
Cardiovascular journal of Africa
Dalby AJ, Aalbers JL.
PMID: 24217048
Cardiovasc J Afr. 2013 May;24(4):147-8.
No abstract available.
Cite
Dalby AJ, Aalbers JL. Congress report: Cardiology and Diabetes at the Limits, 22-25 March 2013. Cardiovasc J Afr. 2013;24(4):147-8
Dalby, A. J., & Aalbers, J. L. (2013). Congress report: Cardiology and Diabetes at the Limits, 22-25 March 2013. Cardiovascular journal of Africa, 24(4), 147-8.
Dalby, A J, and Aalbers, J L. "Congress report: Cardiology and Diabetes at the Limits, 22-25 March 2013." Cardiovascular journal of Africa vol. 24,4 (2013): 147-8.
Dalby AJ, Aalbers JL. Congress report: Cardiology and Diabetes at the Limits, 22-25 March 2013. Cardiovasc J Afr. 2013 May;24(4):147-8. PMID: 24217048.
Copy
Download .nbib
Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Gajos G, Piłaciński S, Zozulińska-Ziółkiewicz D.
PMID: 24431305
Adv Clin Exp Med. 2013 Nov-Dec;22(6):777-84.
Incidence of diabetes is increasing worldwide at an alarming rate. Therefore, a proper understanding of the mechanisms and efficient treatment of the disease is becoming increasingly important. The article briefly describes controversies in type 1 diabetes (T1DM) pathogenesis and...
Cite
Gajos G, Piłaciński S, Zozulińska-Ziółkiewicz D. Controversies in diabetes in 2013 - a brief update. Adv Clin Exp Med. 2013;22(6):777-84
Gajos, G., Piłaciński, S., & Zozulińska-Ziółkiewicz, D. (2013). Controversies in diabetes in 2013 - a brief update. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 22(6), 777-84.
Gajos, Grzegorz, et al. "Controversies in diabetes in 2013 - a brief update." Advances in clinical and experimental medicine : official organ Wroclaw Medical University vol. 22,6 (2013): 777-84.
Gajos G, Piłaciński S, Zozulińska-Ziółkiewicz D. Controversies in diabetes in 2013 - a brief update. Adv Clin Exp Med. 2013 Nov-Dec;22(6):777-84. PMID: 24431305.
Copy
Download .nbib
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Tonelli M, Pottie K.
PMID: 23423276
CMAJ. 2013 Feb 19;185(3):238. doi: 10.1503/cmaj.113-2103.
No abstract available.
Cite
Tonelli M, Pottie K. Diabetes guidelines. CMAJ. 2013;185(3):238doi: 10.1503/cmaj.113-2103.
Tonelli, M., Pottie, K. (2013). Diabetes guidelines. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 185(3), 238. https://doi.org/10.1503/cmaj.113-2103
Tonelli, Marcello, et al. "Diabetes guidelines." CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne vol. 185,3 (2013): 238. doi: https://doi.org/10.1503/cmaj.113-2103
Tonelli M, Pottie K. Diabetes guidelines. CMAJ. 2013 Feb 19;185(3):238. doi: 10.1503/cmaj.113-2103. PMID: 23423276; PMCID: PMC3576447.
Copy
Download .nbib
